Zomedica Corp

(NYSE MKT:ZOM)

Latest On Zomedica Corp (ZOM):

Date/Time Type Description Signal Details
2023-05-12 02:42 ESTNewsZomedica GAAP EPS of $-0.007, revenue of $5.5MN/A
2023-05-12 02:42 ESTNewsZomedica Corp. (ZOM) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 17:22 ESTNewsZomedica acquires Structured Monitoring ProductsN/A
2023-03-17 16:30 ESTNewsZomedica hires new finance chiefN/A
2023-03-16 09:59 ESTNewsZomedica Corp. (ZOM) Q4 2022 Earnings Call TranscriptN/A
2023-03-15 19:07 ESTNewsZomedica reports Q4 resultsN/A
2023-03-15 19:07 ESTNewsZomedica expands topline thanks to acquisitions and organic growthN/A
2023-02-09 17:45 ESTNewsZomedica stock rises as prelim Q4 revenue soars, CEO eyes growth via acquisitionsN/A
2023-01-20 11:46 ESTNewsZomedica stock rises ~15% on taking control of Truforma products via licensing dealN/A
2023-01-18 12:57 ESTNewsZomedica stock rises ~15% on taking control of Truforma products via licesing dealN/A
2023-01-17 13:55 ESTNewsZomedica, Structured Monitoring to start selling remote monitoring system VetGuardianN/A
2023-01-09 22:13 ESTNewsZomedica: High Risk High Reward Play In Veterinary SuppliesN/A
2022-11-15 10:23 ESTNewsZomedica GAAP EPS of -$0.005, revenue of $4.78MN/A
2022-09-13 02:21 ESTNewsZomedica: Growing Veterinary Supply Company, Building Big Things On The ComeN/A
2022-09-08 20:01 ESTNewsZomedica (ZOM) Investor Presentation - SlideshowN/A
2022-08-16 00:05 ESTNewsZomedica GAAP EPS of -$0.005, revenue of $4.2MN/A
2022-07-18 20:23 ESTNewsZomedica acquires assets of Assisi Animal Health LLCN/A
2022-06-28 13:15 ESTNewsZomedica named official shock wave therapy supplier for the U.S. equestrian teamN/A
2022-06-15 17:41 ESTNewsZomedica to acquire innovative veterinary imaging company, Revo Squared assetsN/A
2022-05-19 11:31 ESTNewsZomedica makes strategic investment to acquire pet monitoring platformN/A
2022-05-10 17:30 ESTNewsZomedica reports Q1 resultsN/A
2022-02-25 17:04 ESTNewsZomedica GAAP EPS of -$0.05 misses by $0.04, revenue of $4.1M misses by $0.3MN/A
2022-02-25 17:04 ESTNewsZomedica gains as new acquisition drives Q4 topline growthN/A
2021-11-13 07:00 ESTNewsZomedica reports Q3 resultsN/A
2021-11-13 07:00 ESTNewsZomedica posts widening Q3 net loss as SG&A expenses more than doubleN/A
2021-10-04 16:53 ESTNewsZomedica appoints Larry Heaton as President AND CEON/A
2021-10-02 00:49 ESTNewsZomedica gains on acquisition of PulseVet for $70.9MN/A
2021-08-12 06:58 ESTNewsZomedica Pharmaceuticals reports Q2 resultsN/A
2021-08-12 06:57 ESTNewsZomedica to launch fT4 and ACTH assays before the end of yearN/A
2021-07-22 10:14 ESTNewsZomedica: Should Definitely Be On Your WatchlistN/A
2021-04-15 10:32 ESTNewsZomedica to build direct sales force for TRUFORMA platformN/A
2021-04-13 22:51 ESTNewsZomedica Could Be A Buy As They Look To Disrupt The Veterinary Diagnostics FieldN/A
2021-04-12 10:53 ESTNewsHow TRUFORMA Changes Zomedica's ValuationN/A
2021-03-17 12:27 ESTNewsZomedica commercially launches Truforma ahead of the scheduleN/A
2021-02-28 04:43 ESTFinancialsCompany financials have been released.Neutral
2021-02-27 04:26 ESTNewsZomedica Pharmaceuticals reports Q4 resultsN/A
2021-02-10 21:52 ESTNewsZomedica, Nemaura and Senseonics extend premarket gainsN/A
2021-02-10 21:51 ESTNewsLooking At Zomedica's Potential Amid Recent Run-UpN/A
2021-02-10 21:51 ESTNewsZomedica pops post-market after $25M equity offeringN/A
2021-02-10 21:50 ESTNewsZomedica secures $173.5M capital raiseN/A
2021-02-01 04:54 ESTAnalyst RatingThe Analyst Target Price has increased from $0.5 to $1.2.Buy
2021-01-25 09:14 ESTNewsZomedica inks Truforma distribution deal with Miller Veterinary SupplyN/A
2021-01-21 16:49 ESTNewsZomedica is one popular stock in Robinhood as company fortifies liquidityN/A
2021-01-19 19:59 ESTNewsZomedica raises $40M in warrants exercise, gains NYSE listing complianceN/A
2021-01-14 11:21 ESTNewsZomedica, Tonix, Biolase caught up in social media frenzyN/A
2021-01-12 15:57 ESTNewsZomedica's new diagnostic platform a game changer - Motley FoolN/A
2021-01-12 15:57 ESTNewsZomedica Nears Major Catalyst In TRUFORMA Product LaunchN/A
2021-01-04 17:05 ESTNewsZomedica appoints Robert Cohen as CEON/A
2020-11-26 22:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 05:47 ESTFinancialsCompany financials have been released.Neutral

About Zomedica Corp (ZOM):

Zomedica Corp., a development stage veterinary diagnostic and pharmaceutical company, engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. Its lead drug product candidate is ZM-007, an oral suspension formulation of metronidazole for the treatment of acute diarrhea in small dog breeds and puppies. The company is also developing ZM-012, a tablet formulation of metronidazole targeting the treatment of acute diarrhea in dogs; ZM-006, a transdermal gel formulation of methimazole targeting hyperthyroidism in cats; and ZM-011, a transdermal gel formulation of fluoxetine for the treatment of feline behavioral disorders, such as inappropriate urination. It has a collaboration agreement with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and with Seraph Biosciences, Inc. for development and commercialization of novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.

ZOM Quotes by TradingView

See Advanced Chart

General

  • Name Zomedica Corp
  • Symbol ZOM
  • Type Common Stock
  • Exchange NYSE MKT
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 19
  • Fiscal Year EndDecember
  • IPO Date2016-07-29
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://zomedica.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 43.59
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.01
  • Return on Assets -30%
  • Return on Equity -52%
  • Earnings Per Share -$0.24
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 2.04 billion
  • EBITDA -24073648
  • PE Ratio -3.7
  • Analyst Target Price $1.2
  • Book Value Per Share $0.08
View More

Share Statistics

  • Shares Outstanding 972.02 million
  • Shares Float 922.24 million
  • % Held by Insiders 442%
  • % Held by Institutions 6.33%
  • Shares Short 54.41 million
  • Shares Short Prior Month 63.22 million
  • Short Ratio 0.35
  • Short % of Float 6%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 0.54
  • 52 Week High $2.9
  • 52 Week Low $0.06
  • 50 Day Moving Average 1.96
  • 200 Day Moving Average 0.67
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Zomedica Corp (ZOM) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Zomedica Corp (ZOM) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-26$N/A-$0.01$0.00
2020-09-302020-11-12$N/A-$0.01$0.00
2020-06-302020-08-10$N/A-$0.02-$0.01-100%
2020-03-312020-05-11$N/A-$0.02-$0.020%
2019-12-312020-02-26$N/A-$0.03-$0.02-50%
2019-09-302019-11-12$N/A-$0.03-$0.02-50%
2019-06-302019-08-08$N/A-$0.02-$0.0666.67%
2019-03-312019-05-10$N/A-$0.12
2018-12-312019-02-26$N/A-$0.09
2018-09-302018-09-30$N/A-$0.02
2018-06-302018-06-30$N/A-$0.04
2018-03-312018-03-31$N/A-$0.02
2017-09-302017-09-30$N/A-$0.02
2017-06-302017-06-30$N/A-$0.02
2017-03-312017-03-31$N/A-$0.02
2016-12-312016-12-31$N/A-$0.04
2016-09-302016-09-30$N/A-$0.01

Zomedica Corp (ZOM) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Zomedica Corp (ZOM) Chart:

Zomedica Corp (ZOM) News:

Below you will find a list of latest news for Zomedica Corp (ZOM) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Zomedica Corp (ZOM) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest ZOM Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST200$0.238
Jun 13, 2022 7:59 PM EST200$0.238
Jun 13, 2022 7:59 PM EST100$0.238
Jun 13, 2022 7:59 PM EST168$0.238
Jun 13, 2022 7:59 PM EST100$0.238

Zomedica Corp (ZOM) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-02SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1684144/000143774920014549/0001437749-20-014549-index.htm
2018-12-26UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1684144/000000000018039200/0000000000-18-039200-index.htm
2020-05-19UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1684144/000000000020004461/0000000000-20-004461-index.htm
2020-06-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1684144/000000000020005649/0000000000-20-005649-index.htm
2018-04-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571818000403/0000905718-18-000403-index.htm
2018-05-18DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571818000530/0000905718-18-000530-index.htm
2018-05-18DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571818000532/0000905718-18-000532-index.htm
2018-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571818000544/0000905718-18-000544-index.htm
2018-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571818000552/0000905718-18-000552-index.htm
2018-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571818000563/0000905718-18-000563-index.htm
2018-08-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571818000775/0000905718-18-000775-index.htm
2018-10-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571818000845/0000905718-18-000845-index.htm
2018-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571818000960/0000905718-18-000960-index.htm
2018-12-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571818001001/0000905718-18-001001-index.htm
2019-05-30DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571819000495/0000905718-19-000495-index.htm
2019-08-193Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571819000710/0000905718-19-000710-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571819000712/0000905718-19-000712-index.htm
2020-02-14DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571820000188/0000905718-20-000188-index.htm
2020-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571820000597/0000905718-20-000597-index.htm
2020-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571820000599/0000905718-20-000599-index.htm
2020-07-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571820000734/0000905718-20-000734-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000090571820001030/0000905718-20-001030-index.htm
2020-02-21SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1684144/000091957420001839/0000919574-20-001839-index.htm
2020-06-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1684144/000091957420003980/0000919574-20-003980-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1684144/000110465919008455/0001104659-19-008455-index.htm
2018-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184318003785/0001171843-18-003785-index.htm
2018-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1684144/000117184318003958/0001171843-18-003958-index.htm
2018-05-15424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1684144/000117184318003968/0001171843-18-003968-index.htm
2018-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184318003978/0001171843-18-003978-index.htm
2018-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184318004659/0001171843-18-004659-index.htm
2018-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184318004727/0001171843-18-004727-index.htm
2018-06-19424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1684144/000117184318004729/0001171843-18-004729-index.htm
2018-06-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184318004895/0001171843-18-004895-index.htm
2018-07-05DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1684144/000117184318005061/0001171843-18-005061-index.htm
2018-07-12DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1684144/000117184318005162/0001171843-18-005162-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184318005940/0001171843-18-005940-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1684144/000117184318005946/0001171843-18-005946-index.htm
2018-08-09424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1684144/000117184318005948/0001171843-18-005948-index.htm
2018-08-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184318006110/0001171843-18-006110-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184318007908/0001171843-18-007908-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1684144/000117184318007914/0001171843-18-007914-index.htm
2018-11-13424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1684144/000117184318007916/0001171843-18-007916-index.htm
2018-11-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184318008194/0001171843-18-008194-index.htm
2018-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184318008522/0001171843-18-008522-index.htm
2018-12-20S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1684144/000117184318008523/0001171843-18-008523-index.htm
2018-12-26S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1684144/000117184318008559/0001171843-18-008559-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319000259/0001171843-19-000259-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319000260/0001171843-19-000260-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319000261/0001171843-19-000261-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319000262/0001171843-19-000262-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319000263/0001171843-19-000263-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319000264/0001171843-19-000264-index.htm
2019-01-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319000266/0001171843-19-000266-index.htm
2019-01-17S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1684144/000117184319000333/0001171843-19-000333-index.htm
2019-01-18S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1684144/000117184319000364/0001171843-19-000364-index.htm
2019-01-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319000491/0001171843-19-000491-index.htm
2019-01-28CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1684144/000117184319000552/0001171843-19-000552-index.htm
2019-01-28S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1684144/000117184319000553/0001171843-19-000553-index.htm
2019-01-30DEL AMDelaying amendmenthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319000594/0001171843-19-000594-index.htm
2019-02-01424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1684144/000117184319000675/0001171843-19-000675-index.htm
2019-02-08424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1684144/000117184319000823/0001171843-19-000823-index.htm
2019-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1684144/000117184319001229/0001171843-19-001229-index.htm
2019-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319001231/0001171843-19-001231-index.htm
2019-03-08POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1684144/000117184319001608/0001171843-19-001608-index.htm
2019-03-124/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319001649/0001171843-19-001649-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319001650/0001171843-19-001650-index.htm
2019-03-1410-K/AAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1684144/000117184319001710/0001171843-19-001710-index.htm
2019-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319001790/0001171843-19-001790-index.htm
2019-03-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1684144/000117184319001963/0001171843-19-001963-index.htm
2019-03-25424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1684144/000117184319001964/0001171843-19-001964-index.htm
2019-03-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319002002/0001171843-19-002002-index.htm
2019-03-27424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1684144/000117184319002003/0001171843-19-002003-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319002177/0001171843-19-002177-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1684144/000117184319003257/0001171843-19-003257-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319003262/0001171843-19-003262-index.htm
2019-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319003516/0001171843-19-003516-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1684144/000117184319005323/0001171843-19-005323-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319005331/0001171843-19-005331-index.htm
2019-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319005535/0001171843-19-005535-index.htm
2019-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319005968/0001171843-19-005968-index.htm
2019-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319005969/0001171843-19-005969-index.htm
2019-09-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1684144/000117184319006170/0001171843-19-006170-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319007180/0001171843-19-007180-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1684144/000117184319007462/0001171843-19-007462-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319007466/0001171843-19-007466-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319007924/0001171843-19-007924-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184319008065/0001171843-19-008065-index.htm
2020-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320000367/0001171843-20-000367-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320000912/0001171843-20-000912-index.htm
2020-02-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1684144/000117184320000915/0001171843-20-000915-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1684144/000117184320001304/0001171843-20-001304-index.htm
2020-02-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320001309/0001171843-20-001309-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320001785/0001171843-20-001785-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320001786/0001171843-20-001786-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320001787/0001171843-20-001787-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320001788/0001171843-20-001788-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320001789/0001171843-20-001789-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320001790/0001171843-20-001790-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320001791/0001171843-20-001791-index.htm
2020-03-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320001792/0001171843-20-001792-index.htm
2020-03-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320001804/0001171843-20-001804-index.htm
2020-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320002256/0001171843-20-002256-index.htm
2020-04-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320002429/0001171843-20-002429-index.htm
2020-04-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1684144/000117184320002455/0001171843-20-002455-index.htm
2020-04-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320002486/0001171843-20-002486-index.htm
2020-04-08424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1684144/000117184320002488/0001171843-20-002488-index.htm
2020-04-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320002577/0001171843-20-002577-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320002767/0001171843-20-002767-index.htm
2020-04-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320002860/0001171843-20-002860-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1684144/000117184320003586/0001171843-20-003586-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320003592/0001171843-20-003592-index.htm
2020-05-15S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1684144/000117184320003777/0001171843-20-003777-index.htm
2020-05-21S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1684144/000117184320003903/0001171843-20-003903-index.htm
2020-05-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1684144/000117184320003904/0001171843-20-003904-index.htm
2020-05-22S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1684144/000117184320003958/0001171843-20-003958-index.htm
2020-05-27424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1684144/000117184320004016/0001171843-20-004016-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320004404/0001171843-20-004404-index.htm
2020-06-18S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1684144/000117184320004434/0001171843-20-004434-index.htm
2020-06-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1684144/000117184320004531/0001171843-20-004531-index.htm
2020-06-26424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1684144/000117184320004585/0001171843-20-004585-index.htm
2020-07-018-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320004673/0001171843-20-004673-index.htm
2020-07-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1684144/000117184320004677/0001171843-20-004677-index.htm
2020-07-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320004767/0001171843-20-004767-index.htm
2020-07-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1684144/000117184320004769/0001171843-20-004769-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320004898/0001171843-20-004898-index.htm
2020-07-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320004901/0001171843-20-004901-index.htm
2020-07-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320004902/0001171843-20-004902-index.htm
2020-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320005309/0001171843-20-005309-index.htm
2020-07-29PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320005349/0001171843-20-005349-index.htm
2020-08-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320005498/0001171843-20-005498-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320005754/0001171843-20-005754-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1684144/000117184320005784/0001171843-20-005784-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320005786/0001171843-20-005786-index.htm
2020-08-14DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320005948/0001171843-20-005948-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320005951/0001171843-20-005951-index.htm
2020-08-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320005952/0001171843-20-005952-index.htm
2020-08-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320005953/0001171843-20-005953-index.htm
2020-08-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1684144/000117184320006022/0001171843-20-006022-index.htm
2020-08-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1684144/000117184320006125/0001171843-20-006125-index.htm
2020-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320006126/0001171843-20-006126-index.htm
2020-09-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320006302/0001171843-20-006302-index.htm
2020-09-14DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1684144/000117184320006459/0001171843-20-006459-index.htm
2020-09-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320006707/0001171843-20-006707-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1684144/000117184320006918/0001171843-20-006918-index.htm
2020-10-09S-4Registration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320006978/0001171843-20-006978-index.htm
2020-10-22S-4/ARegistration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320007181/0001171843-20-007181-index.htm
2020-10-26424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1684144/000117184320007235/0001171843-20-007235-index.htm
2020-10-26425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1684144/000117184320007236/0001171843-20-007236-index.htm
2019-12-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1684144/000119312519305862/0001193125-19-305862-index.htm
2019-02-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1684144/000121390019002610/0001213900-19-002610-index.htm
2020-06-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1684144/000121390020014122/0001213900-20-014122-index.htm
2018-09-19SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1684144/000143774918017205/0001437749-18-017205-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1684144/000143774919002636/0001437749-19-002636-index.htm
2020-01-24SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1684144/000143774920001160/0001437749-20-001160-index.htm
2020-07-02SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1684144/000143774920014549/0001437749-20-014549-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1684144/000153561020000072/0001535610-20-000072-index.htm
2019-01-30EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1684144/999999999519000038/9999999995-19-000038-index.htm
2019-03-18EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1684144/999999999519000451/9999999995-19-000451-index.htm
2020-05-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1684144/999999999520001253/9999999995-20-001253-index.htm
2020-06-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1684144/999999999520001697/9999999995-20-001697-index.htm
2020-10-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1684144/999999999520002974/9999999995-20-002974-index.htm
2018-08-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1684144/999999999718007525/9999999997-18-007525-index.htm
2019-03-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1684144/999999999719001292/9999999997-19-001292-index.htm

Zomedica Corp (ZOM) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zomedica Corp (ZOM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 442%
Institutional Ownership: 633%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-06-11Rodney James WilliamsDirectorSell1,000.001.921,920.00135,000.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000563/0000905718-18-000563-index.htm
2018-06-01Rodney James WilliamsDirectorSell500.001.93965.00136,000.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000552/0000905718-18-000552-index.htm
2018-05-31Rodney James WilliamsDirectorSell1,500.001.912,865.00136,500.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000552/0000905718-18-000552-index.htm
2018-05-24Rodney James WilliamsDirectorSell500.001.92960.00138,000.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000544/0000905718-18-000544-index.htm
2018-05-23Rodney James WilliamsDirectorSell12.001.9523.40138,500.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000544/0000905718-18-000544-index.htm
2018-05-23Rodney James WilliamsDirectorSell88.001.91168.08138,512.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000544/0000905718-18-000544-index.htm
2018-05-23Rodney James WilliamsDirectorSell400.001.92768.00138,600.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000544/0000905718-18-000544-index.htm
2018-05-22Rodney James WilliamsDirectorSell500.001.93965.00139,000.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000544/0000905718-18-000544-index.htm
2018-05-21Rodney James WilliamsDirectorSell400.002.00800.00139,500.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000544/0000905718-18-000544-index.htm
2018-05-21Rodney James WilliamsDirectorSell100.002.03203.00139,900.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000544/0000905718-18-000544-index.htm
2018-04-20Stephanie MorleyCOO & VP of Product DevBuy104,000.000.2020,800.001,459,580.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000403/0000905718-18-000403-index.htm
2018-12-20Rodney James WilliamsDirectorBuy26,900.001.2032,280.00161,900.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818001001/0000905718-18-001001-index.htm
2018-08-28James LeBarDirectorSell200,000.002.15430,000.0020,000.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000775/0000905718-18-000775-index.htm
2018-11-29Jeffrey M RoweDirectorBuy175,000.001.20210,000.00275,000.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000960/0000905718-18-000960-index.htm
2018-10-11Gerald JR SolenskyPresident and CEOBuy200,000.001.20240,000.0038,151,100.00https://www.sec.gov/Archives/edgar/data/1684144/000090571818000845/0000905718-18-000845-index.htm
2019-03-08Gerald JR SolenskyPresident and CEOBuy164,473.001.52249,998.9638,315,409.00https://www.sec.gov/Archives/edgar/data/1684144/000117184319001650/0001171843-19-001650-index.htm
2019-03-15Gerald JR SolenskyPresident and CEOBuy164,473.001.52249,998.9638,479,882.00https://www.sec.gov/Archives/edgar/data/1684144/000117184319001790/0001171843-19-001790-index.htm
2019-03-29Gerald JR SolenskyPresident and CEOBuy65,789.001.5299,999.2838,545,671.00https://www.sec.gov/Archives/edgar/data/1684144/000117184319002177/0001171843-19-002177-index.htm
2020-07-07JOHNNY D POWERSDirectorBuy625,000.000.16100,000.00625,000.00https://www.sec.gov/Archives/edgar/data/1684144/000090571820000734/0000905718-20-000734-index.htm